Liver transplant in cystic fibrosis: A poll among European centers. A study from the European Liver Transplant Registry

Transplant International

Volumn 19, Issue 9, 2006, Pages 726-731

  Melzi, Maria L ^a   Kelly, Deirdre A ^b   Colombo, Carla ^c   Jara, Paloma ^d   Manzanares, Javier ^e   Colledan, Michele ^a   Strazzabosco, Mario ^a   Delorenzo, Paola ^f   Valsecchi, Maria G ^f   Adam, René ^g   Gridelli, Bruno ^h   Assael, Baroukh M ⁱ  

^a OSPEDALI RIUNITI   (Italy)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MILAN   (Italy)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f UNIVERSITY OF MILANO BICOCCA   (Italy)

^g HÔPITAL PAUL BROUSSE   (France)

^h MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

ⁱ Centro Fibrosi Cistica   (Italy)

Author keywords

Cystic fibrosis; Epidemiology; Liver transplant; Pulmonary function

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CYSTIC FIBROSIS; DEATH; DECISION MAKING; EUROPE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERSPLENISM; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; QUESTIONNAIRE; REGISTER; RESPIRATORY FUNCTION; RISK FACTOR; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; REGISTRIES; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33746924862     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00344.x     Document Type: Article

References (24)

1. Colombo C, Battezzati PM, Crosignani A, et al. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. Hepatology 2002; 36: 1374.
2. Salvatore F, Scudiero O, Castaldo G. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes. Am J Med Genet 2002; 111: 88.
3. Cystic Fibrosis Foundation. Patient Registry 2000 Annual Report. Bethesda, MD: Cystic Fibrosis Foundation, 2001.
4. Colombo C, Battezzati PM, Podda M, Bettinardi N, Giunta A and the Italian Group for the Study of the Ursodeoxycholic acid in Cystic Fibrosis. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. Hepatology 1996; 23: 1484.
5. Noble-Jamieson G, Barnes ND, Jamieson N, Friend P, Calne R. Liver transplantation for hepatic cirrhosis in cystic fibrosis. J R Soc Med 1996; 89s: 31.
6. Mack DR, Traystman MD, Colombo JL, et al. Clinical denouement and mutation analysis of patients with cystic fibrosis undergoing liver transplantation for biliary cirrhosis. J Pediatr 1995; 127: 881.
7. Mieles LA, Orenstein D, Taperman L, Podesta L, Koneru B, Starzl BE. Liver transplantation in cystic fibrosis. Lancet 1989; 1: 1073.
8. Chavez-Cataya R, Drage M, Jamieson NV, et al. Biliary complications in liver transplantation for cystic fibrosis. Transplant Proc 1999; 31: 2411.
9. Urgelles FE, Bario GAMI, Martinez CMC, et al. Pulmonary function after liver transplantation in cystic fibrosis. Report of 4 cases. An Esp Pediatr 2001; 54: 228.
10. National Institutes of Health. NIH consensus statement on management of hepatitis C. Hepatology 2002; 19: 1.
11. Lindblad A, Glaumann H, Strandvik B. Natural history of liver disease in cystic fibrosis. Hepatology 1999; 30: 1151.
12. Sharp HL. Cystic fibrosis liver disease and transplantation. J Pediatr 1995; 127: 944.
13. Noble-Jamieson G, Barnes ND. Liver transplantation for cirrhosis in cystic fibrosis. J Pediatr 1996; 128: 314.
14. Feigelson J, Anagnostopoulus C, Poquet M, et al. Liver cirrhosis in cystic fibrosis: therapeutic implications and longterm follow-up. Arch Dis Child 1993; 68: 653.
15. Couetil JP, Soubrane O, Houssin DP, et al. Combined heart-lung-liver, double lung-liver, and isolated liver transplantation for cystic fibrosis in children. Transpl Int 1997; 10: 33.
16. Milkiewicz P, Skiba G, Kelly D, et al. Transplantation for cystic fibrosis: outcome following early liver transplantation. J Gastroenterol Hepatol 2002; 17: 208.
17. Mackie AD, Thornton SJ, Edenborough FP. Cystic fibrosis-related diabetes. Diabet Med 2003; 20: 425.
18. Colombo C, Costantini D, Rocchi A, et al. Effects of liver transplantation on the nutritional status of patients with cystic fibrosis. Transpl Int 2005; 18: 246.
19. Dosanjh A. A review of nutritional problems and the cystic fibrosis lung transplant patient. Pediatr Transplant 2002; 6: 388.
20. Ninkovic M, Love SA, Tom B, Alexander GJ, Compston JE. High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcif Tissue Int 2001; 69: 321.
21. Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med 1999; 340: 1081.
22. Ghobrial RM, Farmer DG, Amersi F, Busuttil RW. Advances in pediatric liver and intestinal transplantation. Am J Surg 2000; 180: 328.
23. Rosenstein BJ, Eigen H. Risk of alternative-day prednisone in patients with cystic fibrosis. Pediatrics 1991; 87: 245.
24. Narkewicz MR. Markers of cystic fibrosis-associated liver disease. J Pediatr Gastroenterol Nutr 2001; 32: 421.